🇺🇸 FDA
Patent

US 11679093

2-naphthimidamides, analogues thereof, and methods of treatment using same

granted A61KA61K31/167A61K31/194

Quick answer

US patent 11679093 (2-naphthimidamides, analogues thereof, and methods of treatment using same) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/167, A61K31/194, A61K31/195, A61K31/245